跳至主要内容
临床试验/CTRI/2023/09/057189
CTRI/2023/09/057189尚未招募不适用

Randomized Controlled Trial Of Navayasarasayan Churna And Somaraji Churna In The Management Of ShwitraKustha With Respect To Vitiligo

Sandeep Gorakh Mane1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2024年11月29日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
160
试验地点
1
主要终点
1To Study Kusthgna Effect Of NavayasaRasayan Churna Given In The Dose Of 1 Gm BD With

研究概览

简要总结

shwitra is genral term for whitening of skin .It is a progressive disease, so treatment should start as quickly as possible.

As it is social stigma Shwitra (Vitiligo) is characterized by milky white macules on skin.

Modern medicine has developed many treatment modalities still a large group of people fail to get

the achieved results and is refractory to treatment. In spite of advanced modern technology and

medicine the treatment of Vitiligo is not satisfactory.

So ayurved texts there are no.of formulations described for Shwitra so we decided to study on

Navayasa Rasayan Churna and

Somaraji churnaboth drug are kusthghna property acts on bhrajak pitta.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with SadhyaLakshana of Shwitra.
  • Patients having lesions at axillary, inguinal and buttock region.
  • Patients in the age group of 18 to 60 years.
  • Patches up to 1 year old.
  • Patients of irrespective of sex, religion and socioeconomic status.

排除标准

  • 未提供

结局指标

主要结局

1To Study Kusthgna Effect Of NavayasaRasayan Churna Given In The Dose Of 1 Gm BD With

时间窗: 1To Study Effect Of NavayasaRasayan Churna Given In The Dose Of 1 gm BD With The Koshnajala For 30 Days In The Management Of Shwitra By VASI score at 4th Week

The Koshnajala For 30 Days In The Management Of Shwitra By VASI Score.

时间窗: 1To Study Effect Of NavayasaRasayan Churna Given In The Dose Of 1 gm BD With The Koshnajala For 30 Days In The Management Of Shwitra By VASI score at 4th Week

次要结局

  • To Study The Assessment Criteria Of Shwitra (Vitiligo)(2.To Observes Adverse Effects.)

研究者

发起方
Sandeep Gorakh Mane
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验